| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/19/2013 | WO2013138666A1 Inhibitors of furin and other pro-protein convertases |
| 09/19/2013 | WO2013138236A1 2'- substituted carba-nucleoside analogs for antiviral treatment |
| 09/19/2013 | WO2013138101A2 Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies |
| 09/19/2013 | WO2013137869A1 Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population |
| 09/19/2013 | WO2013137782A1 Agent for the treatment of hepatitis c virus |
| 09/19/2013 | WO2013137563A1 Pharmaceutical composition for preventing or treating tuberculosis |
| 09/19/2013 | WO2013137456A1 Antivirus composition |
| 09/19/2013 | WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF |
| 09/19/2013 | WO2013137197A1 Biofilm inhibitor |
| 09/19/2013 | WO2013135395A1 Composition comprising arabinogalactan and polyphenols from larch trees |
| 09/19/2013 | WO2013135192A1 Novel use of patchoulol |
| 09/19/2013 | WO2013109675A3 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 09/19/2013 | WO2013106410A3 Improved sock for treatment of foot and leg wounds, methods of use and manufacture |
| 09/19/2013 | US20130245575 Body product and method of delivery |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130244987 Compositions and methods for the treatment of skin diseases |
| 09/19/2013 | US20130244928 Antimicrobial peptides and derived metapeptides |
| 09/19/2013 | US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 09/19/2013 | US20130243811 Immunostimulatory oligonucleotides and uses thereof |
| 09/18/2013 | EP2639226A1 Anti-infective pyrimidines and uses thereof |
| 09/18/2013 | EP2639220A1 Indole derivatives and their use as antibiotics |
| 09/18/2013 | EP2638914A1 Composition comprising arabinogalactan and polyphenols from larch trees |
| 09/18/2013 | EP2638161A1 Antisense antibacterial compounds and methods |
| 09/18/2013 | EP2638072A2 Fusion proteins for hiv therapy |
| 09/18/2013 | EP2638061A1 Soluble pd-1 variants, fusion constructs, and uses thereof |
| 09/18/2013 | EP2638060A2 Highly immunogenic hiv p24 sequences |
| 09/18/2013 | EP2638056A1 Use of 2',5'-oligoadenylate derivative compounds |
| 09/18/2013 | EP2638054A1 Uracyl spirooxetane nucleoside phosphoramidates |
| 09/18/2013 | EP2638053A1 Uracyl spirooxetane nucleoside phosphoramidates |
| 09/18/2013 | EP2638006A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
| 09/18/2013 | EP2637654A1 Topical organic acid salt compositions suitable for treating infections |
| 09/18/2013 | EP2637643A2 Pharmaceutical composition for treating hcv infections |
| 09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
| 09/18/2013 | CN103314102A Galectin 9-secreting cell, production method for same, and application for same |
| 09/18/2013 | CN103313982A Phenyl-isoxazol derivatives and preparation process thereof |
| 09/18/2013 | CN103313701A Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 09/18/2013 | CN103305567A Bacillus calmette-guerin compound polysaccharide, and preparation method and use thereof |
| 09/18/2013 | CN103305548A Method for expressing exogenous and endogenous genes by mouse intestinal DC cell mediated by oral gene engineering fermenting yeast and application |
| 09/18/2013 | CN103305542A Recombinant phage double expression vector and application |
| 09/18/2013 | CN103305535A Gene sequence of pig histone deacetylase 6 and application thereof |
| 09/18/2013 | CN103305534A Reverse genetics operating system of mink enteritis virus and application thereof |
| 09/18/2013 | CN103305520A Aptamer sequence of hepatitis B virus core antigen, and applications thereof |
| 09/18/2013 | CN103305519A Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof |
| 09/18/2013 | CN103305475A Establishment method and application of enterovirus (EV) 71-gene modification system |
| 09/18/2013 | CN103305474A Porcine pseudorabies virus strain as well as inactivated vaccine and applications thereof |
| 09/18/2013 | CN103305473A Bluetongue virus serum 1 (BTV1) VP2 protein monoclonal antibody (BTV1-4B6), B-cell epitope polypeptide identified by BTV1-4B6 and application of BTV1-4B6 |
| 09/18/2013 | CN103305472A Bluetongue virus serum 1 (BTV1) VP2 protein monoclonal antibody (BTV1-3E8), B-cell epitope polypeptide identified by BTV1-3E8 and application of BTV1-3E8 |
| 09/18/2013 | CN103305471A Monoclonal antibody BTV8-VP2-4D9 resist ant to bluetongue virus serum 8 type VP2 protein, B-cell epitope peptide identified thereby and application |
| 09/18/2013 | CN103305470A Monoclonal antibody BTV8-VP2-3E11 resistant to bluetongue virus serum 8 type VP2 protein, B-cell epitope peptide identified thereby and application |
| 09/18/2013 | CN103304671A Human rotavirus P[8]deltaVP8*-P[6]deltaVP8* recombinant chimeric protein and application thereof |
| 09/18/2013 | CN103304670A Mycobacterium tuberculosis specific fusion protein vaccine AB and preparation and application thereof |
| 09/18/2013 | CN103304663A Single-chain antibody of chicken Newcastle disease virus P protein, preparation method and use of single-chain antibody |
| 09/18/2013 | CN103304656A PaaspinosaDavid antibacterial peptide and application thereof |
| 09/18/2013 | CN103304646A Mycobacterium tuberculosis candidate antigen polypeptide and application thereof |
| 09/18/2013 | CN103304644A Haemophilus parasuis (Hps) immune protective antigen OppA2 |
| 09/18/2013 | CN103304643A Haemophilus parasuis (Hps) immune protective antigen CdtA |
| 09/18/2013 | CN103304642A Porcine rotavirus delta VP8* subunit recombinant protein and applications thereof |
| 09/18/2013 | CN103304636A Mycobacterium tuberculosis candidate antigen polypeptide and application thereof |
| 09/18/2013 | CN103304628A Nosiheptide derivatives and application thereof |
| 09/18/2013 | CN103304609A Houttuynoid and preparation method and application thereof |
| 09/18/2013 | CN103304604A Clindamycin phosphate compound and preparation method and pharmaceutical composition thereof |
| 09/18/2013 | CN103304600A Voriconazole phosphate trihydrate and preparation method and application thereof |
| 09/18/2013 | CN103304584A 2-hydrazone-thiazolo[4,5-b]quinoxaline compounds, and preparation method and purpose thereof |
| 09/18/2013 | CN103304582A Cefoxitin sodium compound, preparation method and pharmaceutical composition thereof |
| 09/18/2013 | CN103304581A Cefminox sodium compound as well as preparation method and pharmaceutical composition of cefminox sodium compound |
| 09/18/2013 | CN103304580A Cefepime dihydrochloride compound as well as preparation method and medicine composition thereof |
| 09/18/2013 | CN103304579A ortho-positioned bridged azacrown ether modified phthalocyanin and preparation method and application thereof |
| 09/18/2013 | CN103304566A Novel crystalline entecavir |
| 09/18/2013 | CN103304560A Thiazolinone derivatives comprising pyrazoline and thiophene (or furan) structures, and preparation method and application thereof |
| 09/18/2013 | CN103304559A Thiazole derivatives comprising pyrazoline and thiophene (or furan) structures, and preparation method and application thereof |
| 09/18/2013 | CN103304555A Group of benzene-oxazolyl derivatives and preparation method as well as relevant application thereof as IMPDH (Inosine Monophosphate Dehydrogenase) inhibitor |
| 09/18/2013 | CN103304551A Hepatitis C polymerase inhibitor |
| 09/18/2013 | CN103304546A Pyrazoline derivatives comprising 1,4-benzodioxan structure, and preparation method and application thereof |
| 09/18/2013 | CN103304541A Viral polymerase inhibitors |
| 09/18/2013 | CN103304537A Biphenyl cyclooctene lignans compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304534A Preparation method of rosinyl cyclic carbonate and quaternary ammonium salt antibacterial derivative thereof |
| 09/18/2013 | CN103304528A Red anise lactone F, extraction method thereof and application of red anise lactone F in medicine preparation |
| 09/18/2013 | CN103304523A Andrographolide derivative nitric oxide donor compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304489A Pyrimidine benzamide compound and preparation and application thereof |
| 09/18/2013 | CN103304441A O-methoxyphenylacetic acid Schiff base and synthetic method and application thereof |
| 09/18/2013 | CN103304440A 3-[2-(aryl propylenine)hydrazino]-ethyl benzoate compound and application thereof |
| 09/18/2013 | CN103301481A Target nucleic acid drug delivery system and application thereof |
| 09/18/2013 | CN103301477A Application of escherichia coli succinodehydrogenase iron-sulfur protein SdhB |
| 09/18/2013 | CN103301471A Lyophilized vaccine for porcine rotavirus (PRV) |
| 09/18/2013 | CN103301470A Plant sterol glycol chitosan targeting vector, preparation method and application thereof |
| 09/18/2013 | CN103301463A Compound composition containing plumbago zeylanica for treating livestock and poultry escherichia coli infection diseases |
| 09/18/2013 | CN103301462A Component and method for treating virus disease |
| 09/18/2013 | CN103301458A Mucosa adjuvant based on deoxyribose nucleic acid (DNA) receptor as well as preparation and application thereof |
| 09/18/2013 | CN103301457A Preparation method for egg yolk antibody inactivated vaccine resisting loach pathogenic vibrio cholerae |
| 09/18/2013 | CN103301456A Oil-in-water yeast beta glucan nano-emulsion adjuvant as well as preparation method and application thereof |
| 09/18/2013 | CN103301455A Porcine circovirus-haemophilus parasuis bivalent inactivated vaccine and preparation process thereof |
| 09/18/2013 | CN103301454A Lyophilized vaccine for classical swine fever |
| 09/18/2013 | CN103301453A Freeze-dried vaccine for porcine reproductive and respiratory syndrome and preparation method thereof |
| 09/18/2013 | CN103301452A Lyophilized vaccine for swine encephalitis B and preparation method thereof |
| 09/18/2013 | CN103301451A Brucellin live vaccine freezing-drying protecting agent for intradermal injection |
| 09/18/2013 | CN103301450A Plague live vaccine freezing-drying protecting agent for percutaneous scarification |
| 09/18/2013 | CN103301443A Preparation method of stable chicken lyophilized alpha-interferon dosage form |
| 09/18/2013 | CN103301442A Application of BST-2 protein in preparing medicaments for treating diseases caused by influenza A virus |